Zimelidine: a therapeutic and pharmacokinetic study in depression
- PMID: 113803
- DOI: 10.1007/BF00433549
Zimelidine: a therapeutic and pharmacokinetic study in depression
Abstract
Zimelidine, a bicyclic compound with a strong effect on the neuronal reuptake of 5-hydroxy-tryptamine and with weak anticholinergic actions, was evaluated for its antidepressant efficacy in a double-blind comparative trial with amitriptyline. In doses of 200 mg a day it was found to be as effective as 150 mg amitriptyline, but with significantly less subjective side-effects. The plasma concentration of zimelidine and its metabolite, norzimelidine, showed no significant correlation with therapeutic outcome.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources